E. Pons-Tostivint

Statistics

Publications

Citations

H-Index

Active since

2023

Affiliations

Hospital Universitario 12 De Octubre(Current)

Daiichi Sankyo (United States)

Dana-Farber Cancer Institute

Samsung Medical Center

Centre Hospitalier Universitaire de Nantes

E. Pons-Tostivint is an author at Hospital Universitario 12 De Octubre specializing in cancer pharmacogenomics, somatic genomic alterations, and pharmacology.

Publications per year

2023–2025

Publications

1314MO TROPION-Lung05: Datopotamab deruxtecan (Dato-DXd) in previously treated non-small cell lung cancer (NSCLC) with actionable genomic alterations (AGAs)

Luis Paz‐Ares, M-J. Ahn, Aaron Lisberg et al. · Annals of Oncology · 2023 · 50 citations

Medicine, Oncology, Pharmacology +13

518MO TROPION-Lung05: Datopotamab deruxtecan (Dato-DXd) in previously treated non-small cell lung cancer (NSCLC) with actionable genomic alterations (AGAs)

Satoru Kitazono, Luis Paz‐Ares, M-J. Ahn et al. · Annals of Oncology · 2023 · 10 citations · Full text

Medicine, Molecular Genetics, Oncology +13

OA10.01 Intracranial Efficacy of Datopotamab Deruxtecan (Dato-DXd) in Patients With Advanced/Metastatic NSCLC in TROPION-Lung01

E. Pons-Tostivint, Isaku Okamoto, M.-J. Ahn et al. · Journal of Thoracic Oncology · 2025 · 10 citations

Medicine, Oncology, Pharmacotherapy +8

1–3 of 3